NCT04821271: A reported trial by National Institute of Mental Health (NIMH)
This trial has reported on time, in line with the regulations.
Full data
| Full entry on ClinicalTrials.gov | NCT04821271 |
|---|---|
| Title | An Investigation of the Antidepressant Effects of the mGlu2/3 Receptor Antagonist TS-161 in Treatment-Resistant Depression |
| Results Status | Reported |
| ACT or pACT? | This is what FDAAA officially calls an "Applicable Clinical Trial" |
| Start date | June 10, 2021 |
| Completion date | May 23, 2024 |
| Required reporting date | May 23, 2025, midnight |
| Actual reporting date | May 21, 2025 |
| Date last checked at ClinicalTrials.gov | Dec. 12, 2025 |
| Days late | None |